Back to search
FDAFDA · Food and drugs·Recall number D-155-2013

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Published February 13, 2013 · Recall initiated: December 18, 2012

Summary

FDA records drug Class I recall D-155-2013, published February 13, 2013 and initiated December 18, 2012. Recalling firm: Matrixx Initiatives Inc; Status: Terminated; Reported quantity: 46,752 bottles; Lot: Lot # 2J23, Exp 09/15. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Matrixx Initiatives Inc
Distributor
Nationwide.
Lot
Lot # 2J23, Exp 09/15
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0. recalled?

Yes. FDA published recall D-155-2013 on February 13, 2013. Reported hazard: Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release